X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Pfizer with Panacea Biotech - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PFIZER vs PANACEA BIOTECH - Comparison Results

PFIZER    Change

Pfizer India is a 71% subsidiary of the world's largest pharmaceuticals company Pfizer Inc. Pfizer derives a larger share of its revenues from the pharmaceuticals division (81%). The company also has presence in the animal health (13%) and clinical d... More

PANACEA BIOTECH 
   Change

Panacea Biotec is the second largest vaccine producer in India and has been ranked as the third largest biotechnology company in India (as per ABLE Survey 2006). While vaccines account for two-thirds of the company's overall revenues, the balance com... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PFIZER PANACEA BIOTECH PFIZER/
PANACEA BIOTECH
 
P/E (TTM) x 24.2 84.6 28.6% View Chart
P/BV x 3.8 1.9 204.6% View Chart
Dividend Yield % 0.8 0.0 -  

Financials

 PFIZER   PANACEA BIOTECH
EQUITY SHARE DATA
    PFIZER
Mar-16
PANACEA BIOTECH
Mar-14
PFIZER/
PANACEA BIOTECH
5-Yr Chart
Click to enlarge
High Rs2,724149 1,831.9%   
Low Rs1,61182 1,957.5%   
Sales per share (Unadj.) Rs440.984.1 524.0%  
Earnings per share (Unadj.) Rs48.7-18.3 -266.0%  
Cash flow per share (Unadj.) Rs75.8-6.7 -1,131.1%  
Dividends per share (Unadj.) Rs15.000-  
Dividend yield (eoy) %0.70-  
Book value per share (Unadj.) Rs462.983.7 553.0%  
Shares outstanding (eoy) m45.7561.25 74.7%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.91.4 358.2%   
Avg P/E ratio x44.5-6.3 -705.5%  
P/CF ratio (eoy) x28.6-17.2 -165.9%  
Price / Book Value ratio x4.71.4 339.3%  
Dividend payout %30.80-   
Avg Mkt Cap Rs m99,1637,074 1,401.7%   
No. of employees `0002.92.8 105.1%   
Total wages/salary Rs m2,7581,449 190.3%   
Avg. sales/employee Rs Th6,981.71,874.1 372.5%   
Avg. wages/employee Rs Th954.5527.0 181.1%   
Avg. net profit/employee Rs Th771.1-407.7 -189.1%   
INCOME DATA
Net Sales Rs m20,1705,154 391.4%  
Other income Rs m857100 859.1%   
Total revenues Rs m21,0285,254 400.3%   
Gross profit Rs m4,310-766 -562.4%  
Depreciation Rs m1,239711 174.2%   
Interest Rs m51,503 0.3%   
Profit before tax Rs m3,923-2,881 -136.2%   
Minority Interest Rs m011 0.0%   
Prior Period Items Rs m0-6 0.0%   
Extraordinary Inc (Exp) Rs m991,771 5.6%   
Tax Rs m1,79417 10,681.0%   
Profit after tax Rs m2,228-1,121 -198.7%  
Gross profit margin %21.4-14.9 -143.7%  
Effective tax rate %45.7-0.6 -7,842.0%   
Net profit margin %11.0-21.8 -50.8%  
BALANCE SHEET DATA
Current assets Rs m16,2993,810 427.8%   
Current liabilities Rs m7,5948,365 90.8%   
Net working cap to sales %43.2-88.4 -48.8%  
Current ratio x2.10.5 471.2%  
Inventory Days Days65156 41.9%  
Debtors Days Days2667 38.3%  
Net fixed assets Rs m8,62214,480 59.5%   
Share capital Rs m45861 746.3%   
"Free" reserves Rs m20,722903 2,294.6%   
Net worth Rs m21,1805,127 413.1%   
Long term debt Rs m255,832 0.4%   
Total assets Rs m29,13719,433 149.9%  
Interest coverage x755.5-0.9 -82,431.0%   
Debt to equity ratio x01.1 0.1%  
Sales to assets ratio x0.70.3 261.0%   
Return on assets %7.72.0 390.2%  
Return on equity %10.5-21.9 -48.1%  
Return on capital %19.03.6 522.3%  
Exports to sales %0.124.5 0.2%   
Imports to sales %17.510.2 171.7%   
Exports (fob) Rs m121,264 0.9%   
Imports (cif) Rs m3,526525 671.8%   
Fx inflow Rs m521,539 3.4%   
Fx outflow Rs m140942 14.9%   
Net fx Rs m-88597 -14.8%   
CASH FLOW
From Operations Rs m3,436599 573.5%  
From Investments Rs m-6,991-438 1,596.5%  
From Financial Activity Rs m-619-303 204.5%  
Net Cashflow Rs m-4,174-141 2,953.6%  

Share Holding

Indian Promoters % 0.0 74.5 -  
Foreign collaborators % 63.9 0.0 -  
Indian inst/Mut Fund % 7.5 0.6 1,250.0%  
FIIs % 4.9 1.3 376.9%  
ADR/GDR % 0.0 0.0 -  
Free float % 23.7 23.6 100.4%  
Shareholders   85,207 10,259 830.6%  
Pledged promoter(s) holding % 0.0 35.1 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PFIZER With:   FULFORD INDIA  VENUS REMEDIES  STERLING BIOTECH  WOCKHARDT LTD.  SUVEN LIFE  

Compare PFIZER With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Global Markets Remain Volatile Ahead of US Growth Concerns(RoundUp)

Benchmark indices in US corrected marginally by 0.8% during the week. Minutes of Federal Reserve's July meeting are out and the situation looks to be in favor of the emerging markets.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

Aug 7, 2017

The data tells us quite a different story from the one the government is trying to project.

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

Aug 7, 2017

Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

PFIZER SHARE PRICE


Aug 18, 2017 (Close)

TRACK PFIZER

PFIZER - SUVEN LIFE COMPARISON

COMPARE PFIZER WITH

MARKET STATS